News & Analysis on Clinical Trial Services & Contract Research And Development
Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house pipeline.
Patheon, Parexel, and others have all had people on the move in the world of pharmaceutical outsourcing.
Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline and now, true to its word, the French pharma heavyweight has signed a big antibody deal with US biotech Regeneron.
Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs.